SCHEMBL23182201

SCHEMBL23182201

COc1ccccc1C(N)C(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 1/20 0.47
ADRA2B P18089 1/20 0.47
PTGS1 P23219 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LPAR1 Q92633 1/20 0.45
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
ACHE P22303 1/20 0.45
CA12 O43570 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
CTSD P07339 1/20 0.44
KMT2A Q03164 1/20 0.44
CA4 P22748 1/20 0.44
KDM4E B2RXH2 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12665837 0.85 KMT2A (0.53) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL8749509 0.85 KMT2A (0.53) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL3645158 0.85 KMT2A (0.53) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL30550438 0.85 KMT2A (0.53) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL7976422 0.83 CA1 (0.47) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL12310919 0.81 ALDH1A1 (0.47) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL31059192 0.79 MEN1 (0.48) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL13656103 0.78 POLB (0.49) POLBHTTNPSR1L3MBTL1ALDH1A1
SCHEMBL13170107 0.78 POLB (0.49) POLBHTTNPSR1L3MBTL1LPAR1
SCHEMBL15695551 0.78 PTGS1 (0.51) POLBHTTNPSR1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021062246-A1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-04-01 WO disclosed